Dexamethasone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride.
Indications for Dexamethasone sodium phosphate Ophthalmic Solution:
Steroid responsive inflammatory conditions of the eye.
Initial therapy: 1 or 2 drops in conjunctival sac every hour during the day and every two hours during the night. When favorable response observed, reduce dose to 1 drop every 4 hours; may reduce later to 1 drop 3 or 4 times daily.
Epithelial herpes simplex keratitis. Acute infectious stages of vaccinia, varicella, and many other diseases of the cornea and conjunctiva. Mycobacterial infection of the eye. Fungal diseases of ocular or auricular structures. Perforation of a drum membrane.
Monitor intraocular pressure if used for >10 days. Wait at least 15 minutes before inserting contact lenses. Pregnancy (Cat.C). Nursing mothers: not recommended.
Glaucoma with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, perforation of the globe; rare: stinging, burning, filtering blebs following cataract surgery.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Risk of Developing Multiple Sclerosis After HPV Vaccination
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid-Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics